Home Your basket
• Nasal tumours of the thre...
   Price 10.50 €
• Partiturogram: (New) tool...
   Price 10.50 €
• Adenocarcinoma of the eth...
   Price 8.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• The use of ultrasound eva...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Hearing preservation in p...
   Price 10.50 €
• Benign paroxysmal vertigo...
   Price 8.50 €
• Bilateral facial nerve sc...
   Price 10.50 €
• The «neurological» velum ...
   Price 14.00 €
• Unilateral frontal sinus ...
   Price 8.50 €
• Meniere disease : news....
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• What is the effect of diz...
   Price 10.50 €
• Construction and validati...
   Price 10.50 €
• Nasal involvement in Croh...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• A comparative study of br...
   Price 10.50 €
• A specific plain X-ray in...
   Price 8.50 €
• Temporary loss of visual ...
   Price 8.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Evolution of voice assess...
   Price 10.50 €
• Recurrences of pleomorphi...
   Price 10.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• Notes on voice and speech...
   Price 8.50 €
• Multiple intracranial epi...
   Price 14.00 €
• Pulsatile tinnitus and ve...
   Price 8.50 €
• Efficacy and safety of mo...
   Price 10.50 €
• Forcing the voice : the c...
   Price 5.50 €
• The frontal pneumosinus d...
   Price 8.50 €
• Cervical lymph node metas...
   Price 8.50 €
• Acoustic neuroma surgery....
   Price 10.50 €
• Isolated congenital trach...
   Price 10.50 €
• Efficacy of nasal irrigat...
   Price 15.00 €
• Use of a laryngeal mask d...
   Price 8.50 €
• Usher type I syndrome in ...
   Price 10.50 €

Total Order 360.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2002 o

CERVICO-FACIAL SURGERY

Thyroid papillary microcarcinoma. Experience of the Salah Azaiz Institute.


Authors : Z. Oueslati, M. Aloui, S. Gritli, S. Touati, A. El-May, A. Gamoudi, F. Ben-Slimene, A. Ladgham (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2002;123,1:39-42.

Article published in french
Downloadable PDF document french



Summary : The incidence of thyroid papillary microcarcinoma appears to be increasing and therapeutic modalities remain controversial. This retrospective study concerns 25 cases, from 1978 to 1999. The circumstances of diagnosis were: a cervicotomy for thyroid nodule (88% of cases), cervical node metastases (8%), and osseous metastases (4%). The sensitivity of ultrasounds was 22.2%, that of scintigraphy was 9.1% and that of extemporaneous histological examination was 18.2%. Multifocality was found in 16% of cases and bilaterality in 16.6%. Treatment modalities were guided by histological examination. Adjunctive radioiodine ablation was used for 20% of the patients. The treatment of the osseous metastases was completed with external irradiation. The average follow up was 4.8 years (4 months to 19 years), with a rate of survival without disease of 100% .

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE